Bill Ackman Portfolio

Founder of Pershing Square Inc. · 13F portfolio as of Q2 2026

Q2 2026 Summary

First quarter we have for this fund: 15 positions, nothing earlier to compare. Portfolio: $25.5B across 15 positions.

Top Holdings15 positions

Checking export access…
Activity:
PS

Pershing Square Inc.

184.3M$6.1B23.7%$32.680.00%
1 qtr
First report
0
UBER

Uber Technologies, Inc.

34.3M$2.5B9.7%$72.160.00%
1 qtr
First report
0
BN

Brookfield Corporation

57.5M$2.4B9.6%$42.510.00%
1 qtr
First report
0
MSFT

Microsoft Corporation

6.2M$2.3B9.1%$371.600.00%
1 qtr
First report
0
AMZN

Amazon.com, Inc.

8.6M$2B8.0%$238.340.00%
1 qtr
First report
0
HHH

Howard Hughes Holdings Inc.

27.9M$2B7.8%$71.490.00%
1 qtr
First report
0
QSR

Restaurant Brands International Inc.

25.8M$1.9B7.3%$71.870.00%
1 qtr
First report
0
META

Meta Platforms, Inc.

3.2M$1.8B7.1%$562.850.00%
1 qtr
First report
0
V

Visa Inc.

3.3M$1.1B4.4%$341.820.00%
1 qtr
First report
0
MA

Mastercard Incorporated

2.1M$1.1B4.3%$511.960.00%
1 qtr
First report
0
SPGI

S&P Global Inc.

2.6M$1.1B4.1%$384.430.00%
1 qtr
First report
0
NFLX

Netflix, Inc.

13.1M$934M3.7%$71.400.00%
1 qtr
First report
0
PSUS
PSUS
Fund

Pershing Square USA, Ltd.

4M$149.5M0.6%$37.380.00%
1 qtr
First report
0
SEG

Seaport Entertainment Group Inc.

5M$133.6M0.5%$26.600.00%
1 qtr
First report
0
HTZ

Hertz Global Holdings, Inc

15M$34M0.1%$2.27-26.27%
1 qtr
First report
0
$25.5B
AUM
15
Positions
Q2 2026
Filing
HI rating · 4.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q2'26

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

Pershing Square Inc. manages $25.5B across 15 positions as of Q2 2026. Top holdings: PS (23.7%), UBER (9.7%), BN (9.6%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 4/5.0.

Top holdings by portfolio weight

Total AUM$26B
PS23.73%
UBER9.71%
BN9.59%
MSFT9.07%
AMZN8.00%
HHH7.80%
QSR7.34%
META7.05%
V4.40%
MA4.28%
Other4.14%

Portfolio allocation by GICS sector

Sectors6
Financial Services29.60%
Technology24.81%
Consumer Cyclical20.26%
Communication Services14.16%
Real Estate11.00%
Industrials0.18%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Financial Services, Technology, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L59
Conviction80
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Optional analytics helps us improve. How it’s used